A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study,,

OBJECTIVE: To define the maximum tolerated dose (MTD) and assess the feasibility of intravenous (IV) paclitaxel, intraperitoneal (IP) carboplatin, and IP paclitaxel in women with newly diagnosed Stages II–IV ovarian, fallopian tube, or primary peritoneal carcinoma. METHODS: Patients received escalat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gould, Natalie, Sill, Michael W., Mannel, Robert S., Thaker, P.H., DiSilvestro, Paul, Waggoner, Steve, Yamada, S. Diane, Armstrong, Deborah K., Wenzel, Lari, Huang, Helen, Fracasso, Paula M., Walker, Joan L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3670678/
https://ncbi.nlm.nih.gov/pubmed/22155262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.12.417
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi